BMC Cancer
(Oct 2017)
Correction to: Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model
- Yoshitaka Ishihara,
- Satoshi Tsuno,
- Satoshi Kuwamoto,
- Taro Yamashita,
- Yusuke Endo,
- Keigo Miura,
- Yugo Miura,
- Takemasa Sato,
- Junichi Hasegawa,
- Norimasa Miura
Affiliations
- Yoshitaka Ishihara
- Division of Pharmacotherapeutics, Department of Pathophysiological & Therapeutic Science, Faculty of Medicine, Tottori University
- Satoshi Tsuno
- Division of Pharmacotherapeutics, Department of Pathophysiological & Therapeutic Science, Faculty of Medicine, Tottori University
- Satoshi Kuwamoto
- Division of Molecular Pathology, Faculty of Medicine, Tottori University
- Taro Yamashita
- Department of Gastroenterology, Tottori University Hospital
- Yusuke Endo
- Division of Pharmacotherapeutics, Department of Pathophysiological & Therapeutic Science, Faculty of Medicine, Tottori University
- Keigo Miura
- PEZY-Pharma
- Yugo Miura
- Orthopedic Surgery, Tokyo Medical and Dental University
- Takemasa Sato
- Division of Neurobiology, School of Life Science, Faculty of Medicine, Tottori University
- Junichi Hasegawa
- Division of Pharmacotherapeutics, Department of Pathophysiological & Therapeutic Science, Faculty of Medicine, Tottori University
- Norimasa Miura
- Division of Pharmacotherapeutics, Department of Pathophysiological & Therapeutic Science, Faculty of Medicine, Tottori University
- DOI
-
https://doi.org/10.1186/s12885-017-3653-2
- Journal volume & issue
-
Vol. 17,
no. 1
pp.
1
– 3
WeChat QR code